SNP-630

N/A

Report date: 2022/12/29 09:09:25
NME

Base Information

Drug NameSNP-630
Drug Alias NameSNP-630SNP630
ClassificationSmall molecules
Mechanisms of ActionCytochrome P450 inhibitors
TargetsCytochrome P450
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSinew Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSinew Pharma Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A